Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Dermatitis Herpetiformis

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Dermatitis Herpetiformis:

Pubmed Logo
Fibrillar IgA deposition in dermatitis herpetiformis - an underreported pattern with potential clinical significance.
Dermatitis herpetiformis has characteristic clinical and histopathologic...
19th November, 2009
Department of Dermatology, Yale University School of Medicine, New Haven, J Cutan Pathol. 2009 Nov 16.
DOI Direct Link
An unusual case of dermatitis herpetiformis presenting with initial scalp localization.
Dermatitis herpetiformis has characteristic clinical and histopathologic...
17th November, 2009
Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):620-2.
DOI Direct Link
Clinical, histological and immunpathological findings in 32 patients with dermatitis herpetiformis Duhring.
Summary Background: Dermatitis herpetiformis is a chronic severely...
3rd November, 2009
Department of Dermatology, Allergology and Venereology, University of J Dtsch Dermatol Ges. 2009 Oct 28.
DOI Direct Link
Expression of selected ADAMs in bullous pemphigoid and dermatitis herpetiformis.
Bullous dermatoses are a variety of autoimmune skin diseases that are...
3rd November, 2009
J Dermatol Sci. 2009 Oct;56(1):58-61. Epub 2009 Aug 19.
DOI Direct Link
C3d immunohistochemistry on formalin-fixed tissue is a valuable tool in the diagnosis of bullous pemphigoid of the skin.
Background: Direct immunofluorescence (DIF) testing is an important...
30th October, 2009
Kempf & Pfaltz Histological Diagnostics, Zurich, Switzerland. J Cutan Pathol. 2009 Oct 15.
DOI Direct Link

View more research publications.

Press Releases About Dermatitis Herpetiformis:

BioPortfolio Logo
Reportlinker Adds Probiotics - A Global Update of Market Trends & Opportunities 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Probiotics - A Global Update of Market Trends & Opportunities http:/
Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit 24th March, 2009 Avidas Pharmaceuticals, LLC
DOYLESTOWN, Pa., March 24 /PRNewswire/ -- Avidas(TM) Pharmaceuticals, a privately held, specialty pharmaceutical company which focuses on dermatology and women's health, today announced the
American Academy Of Dermatology Holds 67th Annual Meeting 4th March, 2009 American Academy of Dermatology
SCHAUMBURG, Ill., March 4 -- The American Academy of Dermatology (Academy) will hold its 2009 Annual Meeting in San Francisco at the Moscone Center. With an anticipated attendance of more than 17
Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R) 6th November, 2008
KVISTGARD, Denmark, November 6 /PRNewswire/ -- Bavarian Nordic has completed a clinical safety report from a large Phase II study with IMVAMUNE(R) in HIV infected subjects that confirms the excellent
Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program 5th June, 2008 Anesiva, Inc.
SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that it has out-licensed all worldwide rights to its NF-kappa B Decoy (NF-kB Decoy)

BioNews Results for Dermatitis Herpetiformis:

RSS Logo
BioPortfolio Logo
Prediction of Clinical and Mucosal Severity of Coeliac Disease and Dermatitis Herpetiformis by Quantification of IgA/IgG Serum Antibodies to Tissue Transglutaminase
MDLinx:  Oct 20 2009 10:56AM Matching: dermatitis herpetiformis

Dermatitis Herpetiformis Patents:

USPTO Logo
US Patent No.Title
7507737 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H.sub.4receptor
7544808 Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
7547714 Tricyclic compounds, compositions, and methods
7547766 Anti-tango294 antibodies and uses thereof
7547804 Compounds, compositions, and methods employing same

View more patents.

Companies working in the area of Dermatitis Herpetiformis from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

The Coeliac Society of Australia

The Coeliac Society of Australia Inc. was formed in 1980 to provide a forum to promote the national welfare and uniformity of purpose and objectives of the State Coeliac Societies throughout Australia...
www.coeliac.org.au/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Dermatitis Herpetiformis scientists - we have details of around 253 individuals working on Dermatitis Herpetiformis .


This page has been viewed 420 times
Recent Search Terms used to find this page: dermatitis herpetiformis forum | Prediction of Clinical and Mucosal Severity of Coeliac Disease and Dermatitis Herpetiformis | working with dermitatis | dermatitis herpetiformis research | herpetiformis forum | dermatitis herpetiformis research cause | herpetiformis forum | dermatitis herpetiformis australia | dermatitis herpetiformis, australia | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Dermatitis Herpetiformis across BioPortfolio, or for Dermatitis Herpetiformis Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.